The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $179.98

Today's change+0.66 +0.37%
Updated July 21 1:22 PM EDT. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $179.98

Today's change+0.66 +0.37%
Updated July 21 1:22 PM EDT. Delayed by at least 15 minutes.

Amgen Inc Hits New 50-day High

Amgen Inc is up today by (U.S.)$0.66 or 0.37% to (U.S.)$179.98 and setting a new 50-day high. Over the last five days, shares have gained 1.61% and are currently 2.30% off of the 52-week high. Shares have underperformed the S&P 500 by 4.54% during the last year.

Key company metrics

  • Open(U.S.) $179.26
  • Previous close(U.S.) $179.32
  • High(U.S.) $180.55
  • Low(U.S.) $179.16
  • Bid / Ask(U.S.) $179.95 / (U.S.) $179.99
  • YTD % change+23.10%
  • Volume1,286,556
  • Average volume (10-day)2,457,177
  • Average volume (1-month)3,484,955
  • Average volume (3-month)3,633,547
  • 52-week range(U.S.) $133.64 to (U.S.) $184.21
  • Beta1.36
  • Trailing P/E17.05×
  • P/E 1 year forward14.38×
  • Forward PEG3.36×
  • Indicated annual dividend(U.S.) $4.60
  • Dividend yield2.56%
  • Trailing EPS(U.S.) $10.55
Updated July 21 1:22 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue5,4645,9655,8115,688
Total other revenue--------
Total revenue5,4645,9655,8115,688
Gross profit4,4684,8984,7844,638
Total cost of revenue9961,0671,0271,050
Total operating expense2,8733,4803,2843,308
Selling / general / administrative1,0641,3231,2441,292
Research & development7691,078990900
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)---111078
Other operating expenses, total4412323-12
Operating income2,5912,4852,5272,380
Interest income (expense), net non-operating-326-328-325-313
Gain (loss) on sale of assets--------
Other--------
Income before tax2,4602,2832,4182,204
Income after tax2,0711,9352,0171,870
Income tax, total389348401334
Net income2,0711,9352,0171,870
Total adjustments to net income--------
Net income before extra. items2,0711,9352,0171,870
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,0711,9352,0171,870
Inc. avail. to common incl. extra. items2,0711,9352,0171,870
Diluted net income2,0711,9352,0171,870
Dilution adjustment--------
Diluted weighted average shares741742753756
Diluted EPS excluding extraordinary itemsvalue per share2.792.612.682.47
Dividends per sharevalue per share1.151.001.001.00
Diluted normalized EPSvalue per share2.792.482.682.56